Approval BlogMedical CommunicationsOncology Updates Durvalumab receives FDA-approval as a consolidation treatment for Stage III NSCLC By Zachary Moore | Approval Blog, Medical Communications, Oncology Updates
Approval BlogMedical CommunicationsOncology Updates Dabrafenib and Trametinib for the Treatment of BRAF V600E-positive Anaplastic Thyroid Cancer By Zachary Moore | Approval Blog, Medical Communications, Oncology Updates
Approval BlogMedical CommunicationsOncology Updates Tisagenlecleucel for Patients with Relapsed or Refractory Large B-cell Lymphoma By Zachary Moore | Approval Blog, Medical Communications, Oncology Updates
Approval BlogMedical CommunicationsOncology Updates Dabrafenib and Trametinib for Adjuvant Treatment of BRAF V600E/K-Positive Melanoma By Zachary Moore | Approval Blog, Medical Communications, Oncology Updates
Approval BlogMedical CommunicationsOncology Updates Osimertinib for the Frontline Treatment of EGFR-mutant NSCLC By Zachary Moore | Approval Blog, Medical Communications, Oncology Updates
Approval BlogMedical CommunicationsOncology Updates Combination of Nivolumab Plus Ipilimumab for Frontline Treatment of Renal Cell Carcinoma By Zachary Moore | Approval Blog, Medical Communications, Oncology Updates
Approval BlogMedical CommunicationsOncology Updates Rucaparib for Maintenance Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer By Zachary Moore | Approval Blog, Medical Communications, Oncology Updates
Approval BlogMedical CommunicationsOncology Updates Blinatumomab for Patients with MRD-positive B-cell Precursor ALL By Zachary Moore | Approval Blog, Medical Communications, Oncology Updates
Approval BlogMedical CommunicationsOncology Updates Nilotinib Receives FDA-approval to Treat Pediatric Patients with Chronic Phase CML By Zachary Moore | Approval Blog, Medical Communications, Oncology Updates
Approval BlogMedical CommunicationsOncology Updates Apalutamide, a New Treatment for Nonmetastatic Castration Resistant Prostate Cancer By Zachary Moore | Approval Blog, Medical Communications, Oncology Updates
